Irina Staatz-Granzer, Vice Chairman and member of the Supervisory Board, has served on our Supervisory Board since 2009.
Ms. Staatz-Granzer has held business development positions at Hermal, Boots Healthcare International, Knoll, Scil Biomedicals and as CEO of Scil Technology GmbH. Ms. Staatz-Granzer also serves as Chairman of PLCD (German Pharma Licensing Club) and CEO of U3 Pharma.
She founded and is currently CEO of Staatz Business Development & Strategy. She is also Chairman of Talix Therapeutics NV and Emergence Therapeutics AG.
Ms. Staaz-Granzer received a degree in pharmacy from Philipps-Universität Marburg and a Ph.D. from the University of Tübingen.